Home › Funds › SCOGGIN MANAGEMENT LP › LENZ
SCOGGIN MANAGEMENT LP position in LENZ
LENZ THERAPEUTICS INC · Health Care
SCOGGIN MANAGEMENT LP reported holding 175,000 shares of LENZ (LENZ THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$994K, representing 0.33% of its reported portfolio and ranking #34 among its reported holdings. SCOGGIN MANAGEMENT LP has disclosed LENZ holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SCOGGIN MANAGEMENT LP's LENZ position evolved
SCOGGIN MANAGEMENT LP first disclosed a stake in LENZ in Q1 2025 at 100,000 shares (US$2.6M). The position peaked in Q3 2025 at 225,000 shares, worth US$10.5M. Across 6 filings, SCOGGIN MANAGEMENT LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 175,000 shares valued at US$994K — an increase of 50,000 shares quarter over quarter.. Notable position changes include a 100% increase in Q2 2025 (shares rose 59% over the following quarter), a 44% trim in Q4 2025 (shares fell 43% over the following quarter), a 40% increase in Q2 2026 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 100.00K | $2.57M | New |
| Q2 2025 | 200.00K | $5.86M | Add |
| Q3 2025 | 225.00K | $10.48M | Add |
| Q4 2025 | 125.00K | $2.00M | Reduce |
| Q1 2026 | 125.00K | $1.14M | Hold |
| Q2 2026 | 175.00K | $994.00K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LENZ and 13F data
LENZ (LENZ THERAPEUTICS INC) is a Health Care company. 25 other funds we track also report a position in LENZ — the largest reported positions include Alpha Wave Global, LP (US$20.5M), Versant Venture Management, LLC (US$15.1M), 72 Investment Holdings, LLC (US$5.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LENZ
- Alpha Wave Global, LP 3.61M sh · $20.52M · Q2 2026
- Versant Venture Management, LLC 2.66M sh · $15.09M · Q2 2026
- 72 Investment Holdings, LLC 1.02M sh · $5.78M · Q2 2026
- Blue Owl Capital Holdings LP 756.72K sh · $4.30M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 451.11K sh · $2.56M · Q2 2026
More on SCOGGIN MANAGEMENT LP
FAQ
How long has SCOGGIN MANAGEMENT LP held LENZ?
SCOGGIN MANAGEMENT LP has disclosed LENZ holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is SCOGGIN MANAGEMENT LP's current position in LENZ?
As of Q2 2026, SCOGGIN MANAGEMENT LP holds 175.00K shares of LENZ (LENZ THERAPEUTICS INC), valued at $994.00K, representing 0.33% of its reported portfolio and ranking #34.
Has SCOGGIN MANAGEMENT LP been buying or selling LENZ?
In the latest 13F filing (Q2 2026), SCOGGIN MANAGEMENT LP increased its position in LENZ. The position peaked in Q3 2025 at 225.00K shares.
Which other funds hold LENZ?
Other major institutional holders of LENZ include Alpha Wave Global, LP, Versant Venture Management, LLC, 72 Investment Holdings, LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.